Fresenius Medical Care AG & Co. (ADR)  

(Public, NYSE:FMS-)   Watch this stock  
Find more results for FMS-
33.10
0.00 (0.00%)
May 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 25.28 - 36.25
Open     -
Vol / Avg. 0.00/200.00
Mkt cap 21.02B
P/E 19.51
Div/yield 0.49/1.48
EPS 1.70
Shares 635.18M
Beta 0.38
Inst. own 3%
Mar 5, 2013
Fresenius Medical Care at Morgan Stanley European MedTech & Services Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 7.51% 9.62%
Operating margin 14.24% 16.08%
EBITD margin - 19.93%
Return on average assets 4.69% 6.34%
Return on average equity 10.04% 14.10%
Employees 86,855 -
Carbon Disclosure Rating - 55/100

Address

Else-Kroener-Strasse 1
BAD HOMBURG, 61352
Germany
+49-6172-6090 (Phone)
+49-6172-6092301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services. Its dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. The Company operates in two business segments: North America and International. The North America segment consists of Renal Therapy Group and Fresenius Medical Services. The International segment consists of Europe and Latin America and one Asia-Pacific unit. During the year ended December 31, 2010, the Company's subsidiary, U.S. Vascular Access Holdings, LLC, completed the acquisition of National Vascular Care Inc.; it acquired a total of 168 existing clinics, and acquired Gambro AB�s peritoneal dialysis (PD) business. The Company has a total of 1000 subsidiaries worldwide.

Officers and directors

Gerd Krick Chairman of the Supervisory Board
Portrait. Bio & Compensation  - Reuters
Rice Powell Chairman of the Management Board, Chief Executive Officer
Bio & Compensation  - Reuters
Dieter Schenk Vice Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Michael Brosnan Chief Financial Officer, Member of the Management Board
Bio & Compensation  - Reuters
Oliver Maier Senior Vice President of Investor Relations
Bio & Compensation  - Reuters
Rainer Runte Chief Compliance Officer, General Counsel, Member of the Management Board
Portrait. Bio & Compensation  - Reuters
Roberto Fuste Member of the Management Board
Portrait. Bio & Compensation  - Reuters
Emanuele Gatti Member of the Management Board
Portrait. Bio & Compensation  - Reuters
Ronald Kuerbitz Member of the Management Board
Bio & Compensation  - Reuters
Kent Wanzek Member of the Management Board, Global Products Manufacturing Operations
Bio & Compensation  - Reuters